Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03752151 · ClinicalTrials.gov registry record · NA
Micra Atrial TRacking Using A Ventricular AccELerometer 2
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT03752151 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 77 participants.
The verdict
NCT03752151, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
The purpose of the Micra Atrial TRacking Using A Ventricular AccELerometer 2 (MARVEL 2) study is to demonstrate safe and effective operation of the MARVEL 2 features for providing AV synchronous pacing in patients with normal sinus node function and AV block
Interventions
- DEVICE MARVEL 2 Algorithm Monitor Mode then Adaptive Mode
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2019-01-22 |
| Est. Completion | 2019-08-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03752151
The ClinicalTrials.gov registry entry for NCT03752151 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MARVEL 2 Algorithm Monitor Mode then Adaptive Mode is the first listed.
NCT03752151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03752151 about?
NCT03752151 is a clinical study titled "Micra Atrial TRacking Using A Ventricular AccELerometer 2". The purpose of the Micra Atrial TRacking Using A Ventricular AccELerometer 2 (MARVEL 2) study is to demonstrate safe and effective operation of the MARVEL 2 features for providing AV synchronous pacing in patients with normal sinus node function and AV block
What is the current status of trial NCT03752151?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2019-01-22. Estimated completion is 2019-08-07.
What interventions are being tested in trial NCT03752151?
The interventions under investigation include: MARVEL 2 Algorithm Monitor Mode then Adaptive Mode (DEVICE).
Who is sponsoring clinical trial NCT03752151?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.